Abstract
In recent times, bee venom (BV) from honey bee (Apis mellifera L.) has become the focus of interest as a form of alternative and preventive medicine for the treatment of a number of clinical cases such as arthritis, rheumatism, pain, cancer and a vast range of other conditions. BV contains several biochemically and pharmacologically active substances. Some of these compounds are well studied and their mechanisms of action established, despite the fact that few are undergoing clinical trials. Scientists are now performing intensive research work especially human clinical trials to improve the potential use of BV and its chemical constituents as the next drugs generation in the treatment of chronic disorders. Nevertheless, the dual effect of some bee venom components is also important in the design of future therapeutic goals. This paper gives recent evidences on the chemical and biological properties of the major components of bee venom, their underlying molecular action mechanism, and reasons of its consideration as a promising alternative medicine.
Keywords: Alternative medicine, bee venom, biological properties, clinical trials, chronic disorders, molecular mechanism.
Anti-Infective Agents
Title:Bee Venom: Its Potential Use in Alternative Medicine
Volume: 13 Issue: 1
Author(s): Yuva Bellik
Affiliation:
Keywords: Alternative medicine, bee venom, biological properties, clinical trials, chronic disorders, molecular mechanism.
Abstract: In recent times, bee venom (BV) from honey bee (Apis mellifera L.) has become the focus of interest as a form of alternative and preventive medicine for the treatment of a number of clinical cases such as arthritis, rheumatism, pain, cancer and a vast range of other conditions. BV contains several biochemically and pharmacologically active substances. Some of these compounds are well studied and their mechanisms of action established, despite the fact that few are undergoing clinical trials. Scientists are now performing intensive research work especially human clinical trials to improve the potential use of BV and its chemical constituents as the next drugs generation in the treatment of chronic disorders. Nevertheless, the dual effect of some bee venom components is also important in the design of future therapeutic goals. This paper gives recent evidences on the chemical and biological properties of the major components of bee venom, their underlying molecular action mechanism, and reasons of its consideration as a promising alternative medicine.
Export Options
About this article
Cite this article as:
Bellik Yuva, Bee Venom: Its Potential Use in Alternative Medicine, Anti-Infective Agents 2015; 13 (1) . https://dx.doi.org/10.2174/2211352513666150318234624
DOI https://dx.doi.org/10.2174/2211352513666150318234624 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate
Current Cancer Drug Targets Zebrafish Model in Drug Safety Assessment
Current Pharmaceutical Design Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment
Current Pharmaceutical Design Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Patented Aptamers for C-Reactive Protein Detection: A Review About their Use in Clinical Diagnostics
Recent Patents on DNA & Gene Sequences Molecular Bases of Chemoresistance in Cholangiocarcinoma
Current Drug Targets Testosterone Deficiency Syndrome: Cellular and Molecular Mechanism of Action
Current Aging Science An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Sigma-2 Receptor Ligands: Neurobiological Effects
Current Medicinal Chemistry Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy How to Inhibit Telomerase Activity for Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
Current Cancer Drug Targets Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis
Recent Patents on Biomedical Engineering (Discontinued) A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Androgen Receptor in Human Health: A Potential Therapeutic Target
Current Drug Targets Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
Current Pharmaceutical Biotechnology Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Review of the Biological Activity of Maslinic Acid
Current Drug Targets Estrogen(s) and Analogs as a Non-Immunogenic Endogenous Ligand in Targeted Drug/DNA Delivery
Current Medicinal Chemistry